Biovica’s DiviTum(R)TKa in Three Studies at SABCS 2021

UPPSALA, SE / ACCESSWIRE / November 19, 2021 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II)Biovica, active in cancer diagnostics, today announced that results from three different studies using DiviTum®TKa, including a budget impact …